Prevention of HIV-1 Infection with Early Antiretroviral Therapy
By Myron S. Cohen, Ying Q. Chen, M. McCauley, Theresa Gamble, Mina Hosseinipour, N. Kumarasamy, J. Hakim, J. Kumwenda, B. Grinsztejn, J. Pilotto and 25 more. Journal of family planning and reproductive health care, 2011
6,985 citations recorded by the source corpus.
Background Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine countries, we enrolled 1763 couples in which one partner was HIV-1–positive and the other was HIV-1–negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1–infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1:1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1–related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1–negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. Results As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P = 0.01). Conclusions The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy.
Subfields: Epidemiology, Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/905d2c93fc5ec6aacc0190617ab38a1a2ce42054
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Infectious Diseases
In Virology
Citations in the corpus
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. (2016, methodology): “These were eligible for inclusion in this analysis if (1) couples had condomless sex during the period (reported at the end of the period by the HIV-negative partner or, if this partner did not reply, by the positive partner); (2) there was no report of PrEP or PEP use; (3) latest plasma HIV-1 RNA l”
- HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities (2016, background): “The possibility of an AIDS free generation cannot be realized unless we are able to prevent HIV infection in young women.”
- Mucosal Immunity in the Female Genital Tract, HIV/AIDS (2014, background): “It is known that HAART (highly active antiretroviral therapy) reduces HIV-1 concentration in vaginal secretions [287] and in the plasma, as well as the risk of transmission [288, 289], but it does not eliminate it.”
- Handbook of Big Data (2016, background): “We start with some background: An important focus of contemporary statistical research is on methods for large multivariate data.”
- Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough? (2016, background): “ART is important for slowing progression of the disease and reducing HIV transmission to others (Attia, Egger, Müller, Zwahlen, & Low, 2009; Cohen et al., 2011; “Vital Signs,” 2011).”
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013, background): “In addition, early treatment initiation improves survival [4] and reduces the risk of HIV-1 transmission [44].”